Skinvisible, Inc. Signs Development Agreement for Prescription Product for Women's Healthcare

LAS VEGAS, April 13, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) is pleased to announce it has entered into a research and development agreement with Women's Choice Pharmaceuticals LLC, a specialty pharmaceutical company based in Gilbert, Arizona. The agreement is to develop a prescription formulation using Skinvisible's technology Invisicare®, a patented polymer delivery system for topical dermatology and consumer goods products.